DJIA 18,080.78 50.57 0.28%
NASDAQ 4,814.43 40.96 0.86%
S&P 500 2,091.31 9.43 0.45%
market minute promo

Sanofi (ADR) (NYSE: SNY)



company name or ticker
Company Photos
(Click to zoom)

Guru Stocks at 52-Week Lows: HSBC, SNY, WBK, DCM, BBVA

Anika Therapeutics: U.S. Approval To Drive Profit And Valuation

Alnylam Pharmaceuticals Continues To Post Encouraging Results

Overvalued Bonds Or Would You Buy Stocks With A PE Of 100?

Buying These 3 Stocks Is Like Making a Bet in a Burning House

Aegerion Pharmaceuticals, MannKind Corp., and VIVUS, Inc. have all attracted short sellers in droves this year. With each company facing serious headwinds, should investors avoid these struggling biotechs?

Why Is George Soros Buying This Beaten Down Biotech Stock?

Soros Fund Management opened a position in the struggling biotech Aegerion Pharmaceuticals in the third quarter, even while the drugmaker's revenue estimates continued to plummet. Should retail investors follow his lead into this beaten down biotech?

European ADRs Lower on Banking Losses

The Best Healthcare Stocks of 2014: Which Is Our Favorite for 2015?

In this week's Industry Focus, our analysts discuss their favorites of the successful 2014 healthcare large-cap stocks.

Cramer's Lightning Round - Why Did They Fire The Nice Man At Sanofi? (12/17/14)

2 Reasons On Why European Stocks Have Room To Grow

See More Articles...